Blue Jet Healthcare delivered a solid Q2 result with revenue rising to ₹1.65 billion and net profit reaching ₹521.4 million. The company demonstrated strong operational performance and margin expansion, reinforcing its position in the healthcare sector.
                                        
                        
	Blue Jet Healthcare Limited announced its unaudited financial results for the quarter ended September 30, 2025, showcasing impressive revenue growth and profitability. The company's revenue from operations stood at ₹1.65 billion, supported by strong demand across its healthcare products and services.
	
	Net profit surged to ₹521.4 million, reflecting significant operational efficiencies and favorable market conditions. The company has maintained a healthy operating margin, underpinning its sustained earnings growth trajectory. Blue Jet Healthcare's strategic focus on innovation and capacity expansion continues to drive positive financial outcomes.
	
	This performance underscores the company’s strong market position and effective cost management practices, positioning it well for future growth prospects in the healthcare sector.
	
	Key Highlights
	
	Q2 FY2025-26 revenue from operations: ₹1.65 billion
	
	Net profit of ₹521.4 million, indicating strong bottom-line growth
	
	Healthy operating margins and improved profitability
	
	Robust demand driving revenue across product segments
	
	Strategic focus on capacity expansion and innovation boosting growth
	
	Sources: Company SE disclosures, Moneycontrol, Screener.in, Investywise